Strategic Collaborators Advancing mRNA Research to Treat Rare Diseases and Cancer

Biopharma | Government | Foundations | Research Institutes

Our diverse base of strategic collaborators is enabling us to accelerate the promise of mRNA science to deliver a novel class of medicines for patients.  We have forged strategic alliances with pharmaceutical & biotech companies, government organizations, foundations and research institutes with therapeutic area expertise and resources to help advance development programs, leveraging our mRNA platform, research engine and early development engine.